Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

UHS stock hub

Universal Health Services, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

UHSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.3B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

UHS

In the news

Latest news · UHS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.2

P25 12.3P50 18.4P75 33.1

Trailing P/E7.1

P25 14.9P50 23.2P75 38.5

ROE21.4

P25 -105.6P50 -46.5P75 -3.1

ROIC12.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All UHS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

285

Groups with data

Currency

USD

Showing 285 of 285 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000352915
Company name	Universal Health Services, Inc.
Country	United States
Country code	US
Cusip	913903100
Employees	101,500
Employees Change	2,500%
Employees Change Percent	2.53
Enterprise value	$15.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Care Facilities
Isin	US9139031002
Last refreshed	2026-05-10
Market cap	$10.3B
Market cap category	Large-Cap
Price	$170
Price currency	USD
Rev Per Employee	174,978.24x
Sector	Healthcare
Sic	8062
Symbol	UHS
Website	https://uhs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.78%
EV Earnings	10.06x
EV Sales Forward	0.81x
EV/EBIT	7.49x
EV/EBITDA	5.73x
EV/FCF	16.76x
EV/Sales	0.86x
FCF yield	8.87%
Forward P/E	7.18x
P/B ratio	1.38x
P/E ratio	7.08x
P/S ratio	0.58x
PE Ratio10 Y	13.05x
PE Ratio3 Y	11.85x
PE Ratio5 Y	11.66x
PEG ratio	0.9x
PS Forward	0.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.5%
EBITDA Margin	15.02%
FCF margin	5.14%
Gross margin	44.23%
Gross Profit	$7.9B
Gross Profit Growth	14.35%
Gross Profit Growth Q	13.44%
Gross Profit Growth3 Y	14.25%
Gross Profit Growth5 Y	10.6%
Net Income	$1.5B
Net Income Growth	27.06%
Net Income Growth Q	10.11%
Net Income Growth Quarters	10%
Net Income Growth Years	3%
Net Income Growth3 Y	30.51%
Net Income Growth5 Y	8.58%
Pretax Margin	11.38%
Profit Margin	8.56%
Profit Per Employee	$14,983
Profitable Years	35
ROA	8.35
Roa5y	6.52
ROCE	16.42
ROE	21.37
Roe5y	15.51
ROIC	12.49
Roic5y	10.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.85%
Cagr15y	8.39%
Cagr1y	-8.56%
Cagr20y	10.42%
Cagr3y	6.46%
Cagr5y	2.36%
Div CAGR10	7.18%
Div CAGR3	0%
Div CAGR5	31.95%
EPS Growth	34.83
EPS Growth Q	17.71
EPS Growth Quarters	10
EPS Growth Years	3
EPS Growth3 Y	36.61
EPS Growth5 Y	15.27
FCF Growth	-13.61%
FCF Growth Q	52.43%
FCF Growth3 Y	87.44%
FCF Growth5 Y	-4.27%
OCF Growth	-6.14%
OCF Growth Q	11.55%
OCF Growth10 Y	4.52%
OCF Growth3 Y	31.34%
OCF Growth5 Y	-0.25%
Revenue Growth	10.42x
Revenue Growth Q	9.65x
Revenue Growth Quarters	23x
Revenue Growth Years	15x
Revenue Growth3 Y	9.37x
Revenue Growth5 Y	8.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.16
Assets	$15.7B
Cash	$119M
Current Assets	$3.5B
Current Liabilities	$3.2B
Debt	$5.1B
Debt EBITDA	$1.82
Debt Equity	$0.67
Debt FCF	$5.62
Equity	$7.6B
Interest Coverage	13.26
Liabilities	$8.1B
Long Term Assets	$12.2B
Long Term Liabilities	$4.8B
Net Cash	$-5B
Net Cash By Market Cap	$-48.66
Net Debt EBITDA	$1.88
Net Debt Equity	$0.66
Net Debt FCF	$5.49
Tangible Book Value	$3.5B
Tangible Book Value Per Share	$57.56
WACC	7.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.08
Inventory Turnover	43.88
Net Working Capital	$965.7M
Quick ratio	0.88
Working Capital	$255.6M
Working Capital Turnover	$35.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.82%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$0.8
Dividend Years	24
Dividend Yield	0.47%
Ex Div Date	2026-03-02
Last Dividend	$0.2
Payout Frequency	Quarterly
Payout Ratio	3.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	32.45%
1Y total return	-8.55%
200-day SMA	200.6
3Y total return	20.66%
50-day SMA	183.1
50-day SMA vs 200-day SMA	50under200
5Y total return	12.38%
All Time High	246.3
All Time High Change	-31%
All Time High Date	2025-11-26
All Time Low	1.34
All Time Low Change	12,545.83%
All Time Low Date	1991-11-27
ATR	6.33
Beta	1.13
Beta1y	0.69
Beta2y	0.53
Ch YTD	-22.04
High	175
High52	246.3
High52 Date	2025-11-26
High52ch	-31%
Low	168.8
Low52	152.3
Low52 Date	2025-07-29
Low52ch	11.58%
Ma50ch	-7.17%
Premarket Change Percent	1.34
Premarket Price	$173
Premarket Volume	1,705
Price vs 200-day SMA	-15.26%
RSI	41.98
RSI Monthly	45.79
RSI Weekly	36.21
Sharpe ratio	-0.23x
Sortino ratio	-0.15
Total Return	6.29%
Tr YTD	-21.97
Tr15y	234.94%
Tr1m	-5.9%
Tr1w	1.77%
Tr3m	-22.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	1
Analyst Price Target Top	$310
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$5.43
Earnings EPS Estimate Growth	12.19
Earnings Revenue Estimate	4,382,107,992x
Earnings Revenue Estimate Growth	6.88x
Operating Income	$2B
Operating Income Growth	16.83
Operating Income Growth Q	10.56
Operating Income Growth3 Y	22.64
Operating Income Growth5 Y	7.56
Operating margin	11.5
Price target	$217
Price Target Change	$27.73
Price Target Change Top	$82.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,317,175%
Float Percent	83.12%
Net Borrowing	54,000,000
Shares Insiders	14.29%
Shares Institutions	86.22%
Shares Out	60,536,351
Shares Qo Q	-2.36%
Shares Yo Y	-5.82%
Short Float	4.15%
Short Ratio	3.17
Short Shares	3.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$816.1M
Average Volume	890,601.65x
Bv Per Share	123.3
CAPEX	$-993.3M
Ch10y	26.96
Ch15y	212.5
Ch1m	-5.9
Ch1w	1.77
Ch1y	-8.91
Ch20y	557.6
Ch3m	-22.24
Ch3y	19.02
Ch5y	9.52
Ch6m	-25.86
Change	-0.35%
Change From Open	-2.24
Close	170.6
Days Gap	1.93
Depreciation Amortization	625,824,000
Dollar Volume	188,607,501.3
Earnings Date	2026-04-27
Earnings Time	amc
EBIT	$2B
EBITDA	$2.7B
EPS	$23.99
F Score	7
FCF	$912.7M
FCF EV Yield	5.97x
FCF Per Share	$15.08
Financing CF	-880,201,000
Fiscal Year End	December
Founded	1,978
Goodwill	3,980,656,000
Graham Number	258.01727
Graham Upside	51.81
Income Tax	$472.6M
Investing CF	-996,897,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2009-12-16
Last Split Type	Forward
Last10k Filing Date	2026-02-25
Lynch Fair Value	$206
Lynch Upside	21.08
Ma150	206.9
Ma150ch	-17.83%
Ma20	174.3
Ma20ch	-2.51%
Net CF	28,827,000
Next Earnings Date	2026-07-27
Open	173.9
Optionable	Yes
P FCF Ratio	11.27
P OCF Ratio	5.4
Payment Date	2026-03-16
Position In Range	18.58
Post Close	170
Postmarket Change Percent	1.59
Postmarket Price	$173
Ppne	7,438,963,000
Pre Close	170.6
Price Date	2026-05-08
Price EBITDA	$3.86
Ptbv Ratio	2.95
Relative Volume	1.25x
Revenue	17,760,291,000x
SBC By Revenue	0.54x
Share Based Comp	96,597,000
Tax By Revenue	2.66x
Tax Rate	23.39%
Tr20y	625.7%
Tr6m	-25.72%
Us State	Pennsylvania
Volume	1,109,717
Z Score	3.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

UHS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.80 annual per share

Payout ratio

+3.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+32.0%

0 consecutive years of growth

Total shareholder yield

+6.3%

Next ex-dividend date: 2026-03-02

Performance

UHS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns UHS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.2%

Float: +83.1% of shares outstanding

Insider ownership

+14.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

UHS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.0

Neutral momentum band

Price vs 200-day MA

-15.3%

50/200-day relationship not available

Beta (5Y)

1.13

Moves roughly with the market

Sharpe ratio

-0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About UHS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current UHS stock rating?

Universal Health Services, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full UHS analysis?

The full report lives at /stocks/UHS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for UHS?

The latest report frames UHS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the UHS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.